CASI Pharmaceuticals (China) Co., Ltd. clinical trials
A country office of CASI Pharmaceuticals, Inc.
The registry lists 1 studies whose lead sponsor is CASI Pharmaceuticals (China) Co., Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 23, 2024.
Registry sponsor names on this page
- CASI Pharmaceuticals (China) Co., Ltd.1 study
Something wrong with this grouping? Tell us on the CASI Pharmaceuticals, Inc. page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All CASI Pharmaceuticals, Inc. studies →
- Evaluate Safety and Efficacy of High-dose Melphalan HCL for Injection in MM Patients With Auto-HSC TransplantationCompletedNCT06425276Phase 4
Sponsor listed in the registry: CASI Pharmaceuticals (China) Co., Ltd.